We are live on ! Find out more
TE

Tema ETFs Portfolio holdings

AUM $3.09B
1-Year Est. Return 72.72%
This Fund
S&P 500
This Quarter Est. Return
+10.92%
1 Year Est. Return
+72.72%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.2B
AUM Growth
+$828M
Cap. Flow
+$758M
Cap. Flow %
62.93%
Top 10 Hldgs %
15.27%
Holding
529
New
364
Increased
105
Reduced
43
Closed
17

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$29.7M
2
MSFT icon
Microsoft
MSFT
+$24.6M
3
AAPL icon
Apple
AAPL
+$17.9M
4
AMZN icon
Amazon
AMZN
+$16.9M
5
META icon
Meta Platforms (Facebook)
META
+$12.7M

Sector Composition

Rank Sector Weight
1 Technology 21.29%
2 Industrials 20.71%
3 Healthcare 17.14%
4 Financials 11.56%
5 Consumer Discretionary 6.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INCY icon
501
Incyte
INCY
$23.5B
$217K 0.02%
+2,556
New +$202K
FOXA icon
502
Fox Class A
FOXA
$23.2B
$215K 0.02%
+3,411
New +$197K
VTRS icon
503
Viatris
VTRS
$20.1B
$208K 0.02%
+21,032
New +$205K
HST icon
504
Host Hotels & Resorts
HST
$16.8B
$207K 0.02%
+12,133
New +$201K
SWK icon
505
Stanley Black & Decker
SWK
$14.2B
$206K 0.02%
+2,773
New +$203K
SJM icon
506
J.M. Smucker
SJM
$12.6B
$206K 0.02%
+1,895
New +$206K
COO icon
507
Cooper Companies
COO
$13.7B
$204K 0.02%
+2,977
New +$211K
UDR icon
508
UDR
UDR
$12.9B
$201K 0.02%
+5,397
New +$211K
AUTL
509
Autolus Therapeutics
AUTL
$386M
$189K 0.02%
115,823
-4,565
-4% -$8.92K
REPL icon
510
Replimune Group
REPL
$814M
$180K 0.01%
42,966
+2,060
+5% +$13.2K
AES icon
511
AES
AES
$10.6B
$152K 0.01%
+11,528
New +$150K
DAWN
512
DELISTED
Day One Biopharmaceuticals
DAWN
$138K 0.01%
19,542
-104,768
-84% -$721K
ACAD icon
513
Acadia Pharmaceuticals
ACAD
$4.25B
-10,596
Closed -$229K
ARVN icon
514
Arvinas
ARVN
$518M
-72,114
Closed -$531K
AXSM icon
515
Axsome Therapeutics
AXSM
$12.4B
-2,327
Closed -$243K
BEP icon
516
Brookfield Renewable
BEP
$10B
-83,130
Closed -$2.12M
CGEM icon
517
Cullinan Oncology
CGEM
$1.05B
-42,692
Closed -$321K
CNI icon
518
Canadian National Railway
CNI
$78.3B
-11,357
Closed -$1.18M
CPRX
519
DELISTED
Catalyst Pharmaceutical
CPRX
-11,352
Closed -$246K
DNLI icon
520
Denali Therapeutics
DNLI
$3.67B
-15,174
Closed -$212K
GFL icon
521
GFL Environmental
GFL
$14.3B
-30,106
Closed -$1.52M
GPCR icon
522
Structure Therapeutics
GPCR
$3.49B
-22,880
Closed -$475K
MREO
523
Mereo BioPharma
MREO
$45.9M
-102,583
Closed -$278K
RACE icon
524
Ferrari
RACE
$63.3B
-469
Closed -$230K
RCKT icon
525
Rocket Pharmaceuticals
RCKT
$348M
-32,030
Closed -$78.5K

Similar funds

Tema ETFs's Q3 2025 Portfolio in Review

As of Q3 2025, Tema ETFs held 529 positions worth $1.2B, up 220% from $377M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Tema ETFs deployed $758M of net new capital in Q3 2025, opening 364 new positions and adding to 105 existing holdings. Its largest new stake was NVIDIA: 170,445 shares worth $31.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 10% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Herc Holdings, an estimated $2.37M trimmed.

  • Tema ETFs's largest Q3 2025 buy was NVIDIA: 170,445 shares worth $31.8M.
  • Tema ETFs added most to JPMorgan Chase in Q3 2025, an estimated $10.3M increase.
  • Tema ETFs's biggest Q3 2025 reduction was Herc Holdings, cutting an estimated $2.37M.
  • Tema ETFs fully exited Brookfield Renewable in Q3 2025, selling an estimated $2.12M.
  • Tema ETFs's ten largest holdings make up 15% of its $1.2B portfolio in Q3 2025.
  • Tema ETFs opened 364 new positions and closed 17 in Q3 2025.
  • Tema ETFs's portfolio value rose 220% quarter-over-quarter to $1.2B.

Based on Tema ETFs's 13F filing for Q3 2025, filed 24 Oct 2025.